The latest biotech news

News and Trends 21 Jun 2016

“The Microbiome will be as big as Biotech in 10 Years”

Isabelle de Cremoux, the CEO of Seventure Partners, was at Labiotech Refresh to tell us when and how she fell in love with the microbiome and what the future holds for this exciting field. De Cremoux is the person behind Seventure, one of the top European VCs and the first in the world to focus mainly […]

June 21, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 21 Jun 2016

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

AstraZeneca and MRC Technology are launching an initiative to find new epigenetic targets in respiratory disease. By picking promising academic research, the two parties expect to lock in new drugs for diseases like asthma. After partnering up with genomics elite for a new biobank, AstraZeneca is again preparing to tap into collaborations with academia. This […]

June 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

GMO Tobacco could Produce cheaper Medicine for Malaria

Researchers from the Max Planck Institute of Molecular Plant Physiology in Potsdam have altered tobacco to produce large yields of artemisinin – the most effective treatment for malaria but still without a cheap and reliable source. Artemisinin is used in the most effective treatments against malaria, the discovery of which was worth a Nobel Prize. […]

June 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

I tried the Amazon for labs, and it makes life way easier!

Ordering a kit for an experiment could quickly become a nightmare. There are an incredible amount of suppliers out there who are selling similar products that could greatly vary in price and quality. Finding a neutral review on these products is also quite hard as all available references tend to be made by suppliers themselves. Have […]

June 20, 2016 - 4 minutesmins - By Joachim Eeckhout

News and Trends 20 Jun 2016

This Sepsis Detection Test saves 24h for Faster Treatment

Curetis has received great results for its diagnostic kit. This new technology to detect sepsis is delivering the same results as standard tests, but it’s faster by 24 hours – critical time to deal with life-threatening infections. Based in Stuttgart (Germany), Curetis was the only German biotech to do an IPO in 2015. It did so with a bang, […]

June 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

Meet the Biotech successfully using Bacteria for Immuno-Oncology

Yes, the title may have surprised you, but it’s true. Vaximm is one of the few biotechs worldwide using bacteria to activate the immune system against cancer. I was really surprised about how elegant the technology is when I had a chat with the Executive Chairman Klaus Breiner at BioEquity in Copenhagen. Vaximm is based in Basel […]

June 20, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 17 Jun 2016

After its drop earlier this year, Genticel goes back up the slope

Genticel has announced that not one but two milestones have been achieved in the development of its products, which focus on immunotherapies for cancers caused by the human papillomavirus. Genticel is developing GTL001 (named ProCervix in Europe) to answer an unmet medical need – the eradication of the virus HPV 16 or 18 (high-risk types that […]

June 17, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 17 Jun 2016

Apogenix’s lead Candidate has more than one Trick up its Sleeve

Apogenix‘s lead candidate APG101, which has shown great results in a phase II study to treat Glioblastoma, has a new target in line. But this time, it’s not against cancer… Apogenix is a Germany-based company developing innovative immuno-oncology therapeutics for cancer and other malignant diseases. It was founded in 2005 and has raised over €90M […]

June 17, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 17 Jun 2016

Effective anti-infectives for medically unmet diseases? Ask Novabiotics

Toulouse was fun, but it’s time to go somewhere new! Fan of the Highlands, the landscapes that made the Harry Potter scenery much more exciting and the Loch Ness Monster? I’m just asking because this week we are going to Scotland! Aberdeen is our final destination, and we are visiting Novabiotics, our Biotech of the […]

June 17, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Jun 2016

Europe’s Leading SynBio Incubator has 13 new Biotechs ready to Hatch

IndieBio is an accelerator program for new ideas in Synthetic Biology. The participants of the most recent edition (Summer 2016) have been hard at work in Ireland since May 3rd – and now you can take a peek at what’s going on. The objective of IndieBio‘s program is to unlock the creative potential of students, researchers or […]

June 16, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 16 Jun 2016

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

Sividon was a spin-off from Siemens, founded in July 2011 – and it was just sold to the American Myriad Genetics ($2.2Bn market cap) for €50M, even though the company raised only €5M over its lifetime. A clear success story that I discussed with Karlheinz Schmelig, partner of Sividon’s Lead investor Creathor Venture. Sividon worked in […]

June 16, 2016 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

“The Microbiome will be as big as Biotech in 10 Years”

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

GMO Tobacco could Produce cheaper Medicine for Malaria

I tried the Amazon for labs, and it makes life way easier!

This Sepsis Detection Test saves 24h for Faster Treatment

Meet the Biotech successfully using Bacteria for Immuno-Oncology

After its drop earlier this year, Genticel goes back up the slope

Apogenix’s lead Candidate has more than one Trick up its Sleeve

Effective anti-infectives for medically unmet diseases? Ask Novabiotics

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Europe’s Leading SynBio Incubator has 13 new Biotechs ready to Hatch

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!